$PSFE Balance Sheet | Understand Stock

$PSFE

$5.39 -$0.17 (3.06%) Close

$PSFE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Financial Position

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021
Assets
Current assets
Cash and cash equivalents
Customer accounts and other restricted cash
Accounts receivable, net of allowance for credit losses of $9,499 and $7,994, respectively
Settlement receivables, net of allowance for credit losses of $4,524 and $4,082, respectively
Prepaid expenses and other current assets
Related party receivables - current
Contingent consideration receivable - current
Derivative financial assets - current
Contingent consideration receivable – current
Total current assets

Deferred tax assets
Property, plant and equipment, net
Operating lease right-of-use assets
Derivative financial assets - non-current
Intangible assets, net
Goodwill
Contingent consideration receivable - non-current
Contingent consideration receivable – non-current
Other assets – non-current
Total assets

Liabilities and equity
Current liabilities
Accounts payable and other liabilities
Short-term debt
Funds payable and amounts due to customers
Operating lease liabilities – current
Income taxes payable
Contingent consideration payable - current
Liability for share-based compensation – current
Derivative financial liabilities – current
Total current liabilities

Non-current debt
Related party payables – non-current
Operating lease liabilities – non-current
Deferred tax liabilities
Warrant liabilities - non-current
Derivative financial liabilities - non-current
Liability for share-based compensation – non-current
Contingent consideration payable - non-current
Other liabilities – non-current
Total liabilities
Shareholder’s equity
Common shares - $0.012 par value; 1,600,000,000 shares authorized; 63,676,383 shares issued and 51,676,354 outstanding as of December 31, 2025 and 62,511,104 shares issued and 59,888,304 outstanding as of December 31, 2024
Additional paid in capital
Accumulated deficit
Treasury shares - at cost; 12,000,029 shares as of December 31, 2025 and 2,622,800 shares as of December 31, 2024
Accumulated other comprehensive loss
Shareholder's equity in the Company

Non-controlling interest
Total shareholder's equity
Total liabilities and shareholder’s equity

Comments